Hospital | |
Obsessive-Compulsive Disorder(OCD)
by
Amy Scholten, MPH DefinitionObsessive-compulsive disorder (OCD) is a mental illness. It consists of unwanted, recurring thoughts (obsessions) and behaviors (compulsions). The person with OCD does not feel able to control this. It can disrupt daily functions. CausesThe exact cause of OCD is not known. The nervous system, environment, and genes may play a role.
Risk FactorsThings that may raise the risk of OCD are:
SymptomsSymptoms of OCD may be:
OCD may happen with:
DiagnosisThe doctor will ask about your symptoms. OCD is diagnosed when symptoms:
TreatmentThe goal is to reduce unwanted thoughts and compulsions. Early treatment can have better results. Options may be:
Sometimes OCD is severe and hard to treat. In this case, options may be:
PreventionThere are no steps for preventing OCD. RESOURCES:Anxiety and Depression Association of America https://adaa.org International OCD Foundation https://iocdf.org CANADIAN RESOURCES:Canadian Mental Health Association https://cmha.ca Canadian Psychiatric Association http://www.cpa-apc.org References:Arya S, Filkowski MM, et al. Deep brain stimulation for obsessive-compulsive disorder. Bull Menninger Clin. 2019;83(1):84-96. Obsessive compulsive disorder (OCD). EBSCO DynaMed website. Available at: https://www.dynamed.com/condition/obsessive-compulsive-disorder-ocd
. Accessed March 12, 2021. Obsessive-compulsive disorder (OCD). National Institute of Mental Health, National Institutes of Health website. Available at:
https://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd/index.shtml. Accessed March 12, 2021.
7/15/2016 DynaMed Systematic Literature Surveillance
http://www.dynamed...
: Fontenelle LF, Coutinho ES, Lins-Martins NM, Fitzgerald PB, Fujiwara H, Yücel M. Electroconvulsive therapy for obsessive-compulsive disorder: a systematic review. J Clin Psychiatry. 2015;76(7):949-957.
11/6/2018 DynaMed Systematic Literature Surveillance
http://www.dynamed...
: FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder. Available at: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm617244.htm.
Last reviewed January 2021 by
EBSCO Medical Review Board
Adrian Preda, MD Last Updated: 03/12/2021 | |